In founding his skincare company, Murad, in 1989, Dr. Murad, MD, FAAD, brought to the world his groundbreaking skincare formulas that produce measurable results without cosmetic surgery. His more recent efforts have focused on Modern Wellness,...
In a recent achievement, DP Technology's hit discovery platform RiDYMO® has successfully designed a cyclic peptide targeting β-catenin, a historically "undruggable" protein, in just two months. This innovative AI-driven approach combines advanced...
of certain items in NLS's extraordinary general meeting on January 7, 2025. As previously detailed in NLS's Report on Form 6-K submitted to the Securities and Exchange Commission on December 4, 2024, this agreement involved no warrants and was...
Calcium/Calmodulin-dependent Protein Kinase II (CaMKII) inhibitor for rare and common cardiovascular diseases. For more information, please visit https://cardurion.com.
the growing demands of the cell and gene therapy industry." PBS' Vertical-Wheel® bioreactors have demonstrated superior performance for production of therapeutic cells designed as regenerative medicines for conditions like diabetes, cancer, and...
co-founder, Dr. Ahna Skop, who discovered that these structures contain RNA and active translation – a finding that transformed our understanding of cellular communication and cancer detection. "MBRs are produced every cell division and they are...
and correction of bone. The Revolution EPS and Revolution Trauma products are available now for all current Fusion and former Metalogix qualified distributors in their respective markets throughout the United States. This groundbreaking technology...
Spyre's pipeline includes investigational extended half-life antibodies targeting α4β7, TL1A, and IL-23. For more information, please visit, www.spyre.com.
and engineering, developability assessment and pharmacological evaluation, leveraging advantages of Harbour Mice®platforms and the experienced therapeutic antibody discovery team. Harbour Mice® generates fully human monoclonal antibodies in...
stapling with its 90° articulation capability, providing surgeons with the maneuverability and precision necessary to perform effective stapling even in the most confined spaces. This innovation potentially reduces the need for multiple stapler...
first compounded semaglutide gummy. Designed to deliver the benefits of GLP-1 medications in a convenient, needle-free format, this innovative format reimagines how individuals approach GLP-1 programs in the United States. Eden believes a healthier...
statements due to certain factors, e.g., changes in business, economic and competitive conditions, regulatory reforms, results of clinical trials, foreign exchange rate fluctuations, uncertainties in litigation or investigative proceedings, and the...
said Dr. Stephen Weeks, VP of Structural Biology at Orthogon Therapeutics. “This achievement highlights our platform’s ability to target previously undruggable viral proteins.” This breakthrough coincides with Orthogon’s creation of a pioneering...
and better outcomes for patients worldwide. "This collaboration marks a significant step forward in our mission to transform lupus nephritis treatment," said Dr. Alon Yaar, CEO of LIVEKIDNEY.BIO. "By joining forces with Isotopia, we are confident...
pioneer in the field of antibody drug conjugates (ADCs). The Company is advancing its proprietary ADC technology to transform the treatment paradigm for patients with hematologic malignancies and solid tumors. ADC Therapeutics' CD19-directed ADC...
Petauri, a leading purpose-built pharmaceutical services platform, announced that Nicole Lodowski, Managing Director of Petauri Evidence, has been recognized as one of MM+M's esteemed 40 Under 40 honorees for 2025. Amanda Peterson, Vice President...
a cross-border functional team and fostering external collaborations to maintain an agile, cost-efficient development platform, driving its efforts to create groundbreaking therapies. For more information please visit https://www.pilatusbio.com/.
obesity therapies, including Semaglutide and Orforglipron, providing robust support for BLX-7006's potential as a transformative treatment for obesity & diabetic indications. The newly completed study builds upon a previous DIO study in which...
compensate for sphincter insufficiency in patients, both men and women, with SUI. It is based on a unique mechatronic platform using embedded smart, digital and robotic systems which, based on data collected from a patient, create a treatment...
research career at Rockefeller University. I was investigating a fundamental question: How do 100 billion connections form in our brain to empower humans to do everything we do? That led me to an interest in ophthalmology, especially retina...
